Search Results 1381-1390 of 18871 for Insulin

  1. Oncoimmune Signaling and Therapeutics - Mayo Clinic Research

    Bcl10 links saturated fat overnutrition with hepatocellular NF-kB activation and insulin resistance. More about research at Mayo Clinic. Research Faculty ...

  2. Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus - Mayo Clinic

    ... insulin or sulfonylurea or treatment within the last 3 months prior to Screening 18. Patients on pioglitazone in the last 12 months prior to Screening ...

  3. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

    Patients with controlled type 1 diabetes mellitus on a stable insulin regimen may be eligible. Patients with eczema, psoriasis, lichen simplex chronicus of ...

  4. COVID and Diabetes Assessment - Clinical Trials

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Study Of GI-102 And PD-1 In Glioblastoma - Mayo Clinic

    NOTE: Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not ...

  6. Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

    No concurrent insulin or growth hormone therapy. More information. Publications. Publications are currently not available. Additional contact information.

  7. COVID-19: Who's at higher risk of serious symptoms? - Mayo Clinic News Network

    The risk of infections, including COVID-19, can be reduced by keeping blood sugar levels controlled and continuing your diabetes medications and insulin.

  8. Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202) - Mayo Clinic

    Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not ...

  9. [Trial Of Device That Is Not Approved Or Cleared By The U.S. FDA] - Mayo Clinic

    Insulin dependent diabetes with HbA1c > 7.0. History of exposure to any recombinant proteins or peptides used for bone formation (i.e., Infuse Bone Graft ...

  10. Publications - Mark J. Hoegger - Mayo Clinic

    Glycemic Regulation and Insulin Secretion Are Abnormal in Cystic Fibrosis Pigs Despite Sparing of Islet Cell Mass Clin Sci (Lond). 2014. Hoegger MJ, Fischer ...